The mechanisms involved in the beneficial actions of GLP-1 receptor agonists on MASLD are indirect, given the virtual absence of GLP-1R in hepatocytes, except for those in T cells which are associated with anti-inflammatory effect.9 These include fat mass reduction, increased hepatic insulin sensitivity, reduced tissue lipotoxicity, anti-inflammatory effect and improved mitochondrial function32 (Fig
Key Background GLP-1 drugs, which were first designated for diabetes treatment, have become wildly popular in the last few years due to their effectiveness and FDA approval as a weight loss drug
10.1074/jbc.M507518200 J
Orthology clusters from gene trees with Possvm
Severe hepatotoxicity is rare, but case reports describe hepatitis and even liver failure
Research-verified information Our content references peer-reviewed studies and verified data, ensuring accuracy, integrity, and real-world relevance